CONTROLLED CLINICAL TRIAL OF INTRAVENOUS ACYCLOVIR IN HEART-TRANSPLANT PATIENTS WITH MUCOCUTANEOUS HERPES SIMPLEX INFECTIONS

Sunwen Chou, James G. Gallagher, Thomas C. Merigan

Research output: Contribution to journalArticle

67 Scopus citations

Abstract

Viral Cultures of mucocutaneous herpes simplex lesions became negative in 5 heart-transplant patients given a 7-day course of intravenous acyclovir. Relief of pain and healing of lesions paralleled the virological response. Similar clinical and virological responses were not seen in the 5 placebo-treated patients in this double-blind placebo-controlled trial. No adverse reactions attributable to acyclovir were noted. Shedding of herpes simplex viruses recurred in 3 patients after acyclovir therapy.

Original languageEnglish (US)
Pages (from-to)1392-1394
Number of pages3
JournalThe Lancet
Volume317
Issue number8235
DOIs
StatePublished - Jun 27 1981

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'CONTROLLED CLINICAL TRIAL OF INTRAVENOUS ACYCLOVIR IN HEART-TRANSPLANT PATIENTS WITH MUCOCUTANEOUS HERPES SIMPLEX INFECTIONS'. Together they form a unique fingerprint.

  • Cite this